XML 26 R16.htm IDEA: XBRL DOCUMENT v3.6.0.2
Commitments and Contingencies (Tables)
 3 Months Ended
Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

 

Fiscal year ending September 30,        
2017   $ 84,142  
2018     112,189  
2019     56,094  
    $ 252,425  
Schedule of exercisable share purchase warrants outstanding

  At December 31, 2016 and September 30, 2016, the Company had 1,809,309 share purchase warrants outstanding with a weighted average exercise price of $2.70 as follows:

 

Number     Exercise Price     Expiry Date
  1,462,180     $ 3.00     July 5, 2018
  30,000     $ 4.00     February 24, 2019
  277,127     $ 1.20     March 13, 2019
  1,252     $ 1.68     March 13, 2019
  31,250     $ 1.24     May 31, 2019
  7,500     $ 1.04     May 31, 2019
  1,809,309              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options for the three months ended December 31, 2016 and for the year ended September 30, 2016 is presented below:

 

    Number of
Shares		     Weighted
Average
Exercise Price		     Weighted
Average Grant
Date fair value		  
Outstanding at October 1, 2015     1,822,500     $ 2.00          
Granted     2,401,500     $ 5.22     $ 4.38  
Expired     (25,000 )   $ 14.68          
Outstanding at September 30, 2016     4,199,000     $ 3.76          
Granted     155,000     $ 3.70     $ 3.16  
Outstanding at December 31, 2016     4,354,000     $ 3.76          
Exercisable at December 31, 2016     2,449,638     $ 2.65          
Exercisable at September 30, 2016     2,290,716     $ 2.41      
Schedule of stock options outstanding

At December 31, 2016, the following stock options were outstanding:

 

Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
  500,000       500,000     $ 1.60     July 5, 2023     1,180,000       6.51  
  75,000       50,000     $ 1.20     May 7, 2024     207,000       7.35  
  125,000       62,500     $ 1.32     May 8, 2024     330,000       7.35  
  718,750       479,170     $ 0.92     April 2, 2025     2,185,000       8.25  
  50,000       25,001     $ 1.44     June 8, 2025     126,000       8.44  
  50,000       16,667     $ 1.76     June 15, 2025     110,000       8.45  
  278,750       139,375     $ 5.04     September 18, 2025     -       8.71  
  1,500       1,500     $ 5.64     September 30, 2025     -       8.75  
  31,250       13,020     $ 5.68     October 2, 2025     -       8.75  
  25,000       10,416     $ 8.98     October 16, 2025     -       8.79  
  1,500       1,500     $ 5.57     December 31, 2025     -       9.00  
  1,500       1,500     $ 4.90     March 31, 2026     -       9.25  
  1,500       1,500     $ 5.66     April 27, 2026     -       9.32  
  50,000       16,288     $ 4.09     May 18, 2026     -       9.38  
  1,500       1,500     $ 6.11     June 30, 2026     -       9.49  
  379,625       31,635     $ 6.26     July 5, 2026     -       9.51  
  861,429       71,785     $ 7.06     July 18, 2026     -       9.54  
  40,000       6,667     $ 3.06     September 7, 2026     36,000       9.68  
  1,006,696       1,006,696     $ 3.28     September 22, 2026     684,553       9.72  
  140,000       11,668     $ 3.63     October 3, 2026     46,200       9.75  
  15,000       1,250     $ 4.35     December 9, 2026     -       9.94  
  4,354,000       2,449,638                 $ 4,904,753          
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

 

    December 31,  
    2016     2015  
General and administrative   $ 427,583     $ 141,829  
Research and development     461,684       74,192  
Total share based compensation   $ 889,267     $ 216,020  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2016     2015  
Risk-free interest rate     1.52 %     1.66 %
Expected life of options (years)     6.95       7.01  
Annualized volatility     111.45 %     101.50 %
Dividend rate     0.00 %     0.00 %